The Clorox Company (NYSE:CLX) Shares Sold by Farther Finance Advisors LLC

Farther Finance Advisors LLC lessened its stake in shares of The Clorox Company (NYSE:CLX) by 3.8% in the third quarter, according to its most recent filing with the SEC. The fund owned 9,342 shares of the company’s stock after selling 372 shares during the period. Farther Finance Advisors LLC’s holdings in Clorox were worth $1,522,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Vanguard Group Inc. lifted its position in shares of Clorox by 0.3% in the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock valued at $2,339,150,000 after acquiring an additional 48,632 shares in the last quarter. Nuance Investments LLC boosted its position in shares of Clorox by 150.6% in the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after buying an additional 960,094 shares during the period. Van ECK Associates Corp grew its holdings in shares of Clorox by 1,715.5% during the second quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock valued at $199,411,000 after buying an additional 1,380,724 shares in the last quarter. Bank of New York Mellon Corp raised its position in Clorox by 14.4% during the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock valued at $131,200,000 after buying an additional 120,716 shares during the period. Finally, Acadian Asset Management LLC lifted its stake in Clorox by 26.5% in the 1st quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock worth $135,099,000 after acquiring an additional 184,847 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Stock Performance

NYSE:CLX opened at $163.11 on Monday. The firm has a market capitalization of $20.19 billion, a PE ratio of 56.83, a PEG ratio of 3.09 and a beta of 0.41. The Clorox Company has a 1 year low of $121.76 and a 1 year high of $169.09. The company has a current ratio of 1.00, a quick ratio of 0.63 and a debt-to-equity ratio of 11.08. The firm’s fifty day simple moving average is $161.48 and its 200 day simple moving average is $146.19.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the business posted $0.49 earnings per share. The firm’s revenue was up 27.0% compared to the same quarter last year. On average, sell-side analysts anticipate that The Clorox Company will post 6.79 EPS for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.99%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.57% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on CLX shares. DA Davidson reiterated a “neutral” rating and issued a $153.00 target price on shares of Clorox in a report on Friday, September 6th. Wells Fargo & Company cut their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. JPMorgan Chase & Co. increased their price objective on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Six research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $150.29.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.